aloxistatin has been researched along with Hypertrophy, Left Ventricular in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allen, DA; Chesser, AM; Harwood, SM; New, DI; Raftery, MJ; Yaqoob, MM | 1 |
1 other study(ies) available for aloxistatin and Hypertrophy, Left Ventricular
| Article | Year |
|---|---|
Calpain is activated in experimental uremia: is calpain a mediator of uremia-induced myocardial injury?
Topics: Acrylates; Animals; Calcium-Binding Proteins; Calpain; Caspase 3; Caspase Inhibitors; Caspases; Cysteine Proteinase Inhibitors; Disease Models, Animal; Humans; Hypertrophy, Left Ventricular; Leucine; Male; Nephrectomy; Oligopeptides; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Uremia | 2003 |